| Name | SEC inhibitor KL-1 |
|---|
| Description | SEC inhibitor KL-1 (KL-1), a peptidomimetic lead compound, is a potent, selective super elongation complex (SEC) inhibitor and disrupts the interaction between the SEC scaffolding protein AFF4 and P-TEFb, resulting in impaired release of Pol II from promoter-proximal pause sites and a reduced average rate of processive transcription elongation. SEC inhibitor KL-1 exhibits an dose-dependent inhibitory effect on AFF4-CCNT1 interaction with a Ki of 3.48 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
SEC[1] |
| References |
| Molecular Formula | C18H16ClNO4 |
|---|---|
| Molecular Weight | 345.78 |